Poseida Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Poseida Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.93 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.93.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.68.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.74.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.62.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.01.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$3.61.
- Poseida Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$6.86.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.93 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$2.01 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$0.68 10-Q · filed 2021-11-09 | -$2.03 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | -$0.74 10-Q · filed 2021-08-12 | -$1.35 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$0.62 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$2.32 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$3.61 10-K · filed 2022-03-10 |
| 2020-09-30 | -$0.63 10-Q · filed 2021-11-09 | -$1.90 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$3.43 10-Q · filed 2021-11-09 | -$4.94 derived: net income ÷ weighted average shares · filed 2021-11-09 |
| 2020-06-30 | -$2.28 10-Q · filed 2021-08-12 | -$4.44 10-Q · filed 2021-08-12 | -$6.23 derived: net income ÷ weighted average shares · filed 2021-08-12 | -$7.90 derived: net income ÷ weighted average shares · filed 2021-08-12 |
| 2020-03-31 | -$2.16 10-Q · filed 2021-05-11 | -$3.95 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$5.62 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$7.92 derived: net income ÷ weighted average shares · filed 2021-05-11 |
| 2019-12-31 | -$1.79 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$3.45 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$5.75 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$6.86 10-K · filed 2021-03-11 |
| 2019-09-30 | -$1.65 10-Q · filed 2020-11-12 | -$3.97 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$5.06 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$2.32 10-Q · filed 2020-08-20 | -$3.41 10-Q · filed 2020-08-20 |